KP Tissue Inc.

KPT.TOTSXConsumer Defensive● Active

$13.16

+$0.09(+0.69%)

Market Cap$131893468

P/E Ratio—

52W High$13.26

52W Low$8.73

Avg Volume14K

Open$13.24

Beta0.40

Free Cash Flow Financials Revenue

KP Tissue Inc. (KPT.TO) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

KPT.TO · free cash flow · updated Jun 8, 2026

Core FCF metrics

KPT.TO · FCF · TTM · margin & CAGR

Free cash flow was $0 for FY2024 (fiscal year ending 2024-12-31), down 100.0% year-over-year

FY2024 Free Cash Flow$0▼ -100.0% YoY

Trailing 12M (TTM)$0trailing 4 quarters sum

FCF Margin——

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

KPT.TO · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2024Latest$0(0M)$0▼ 100.0%—

FY2023$7.0M(0M)$7.0M▲ +5.5%—

FY2022$6.6M(0M)$6.6M▲ +474.9%—

FY2021$1.2M(0M)$1.2M▲ +147.2%—

FY2020−$2.4M(0M)−$2.4M▲ +64.7%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

KPT.TO · P/FCF · FCF yield · FCF per share

KP Tissue Inc. (KPT.TO) reported negative free cash flow of —. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2024 · 2024-12-31

Cash flow statement summary

KPT.TO · cash flow statement · operating / investing / financing

For FY2024, KP Tissue Inc. generated $0 in operating cash flow and spent 0M in capital expenditures, yielding $0 in free cash flow.

Operating Activities

+$0.0M

Cash from core business operations

2024-12-31

Investing Activities

+$7.0M

CapEx, acquisitions & investments

2024-12-31

Financing Activities

−$7.0M

Buybacks, dividends & debt

2024-12-31

FCF FormulaOperating CF ($0) − |CapEx| (0M) = FCF ($0)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Consumer Defensive)

KPT.TO vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

KP Tissue Inc.YOU

KPT.TO

$0-100.0%—

The Procter & Gamble Company

$14.04B-15.0%16.7%

94%

Philip Morris International Inc.

$10.66B-1.0%26.2%

71%

Costco Wholesale Corporation

COST

$7.84B+18.2%2.8%

53%

The Coca-Cola Company

$5.30B+11.7%11.0%

35%

Consumer Defensive · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

KP Tissue Inc. (KPT.TO) reported free cash flow of $0 for FY2024 (fiscal year ending 2024-12-31), down 100.0% year-over-year.

Based on available data, KP Tissue Inc. has maintained positive free cash flow for at least 5 fiscal year(s). FCF peaked at $7.0M in FY2023.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

KPT.TO free cash flow · 8 questions

KP Tissue Inc. free cash flow was $0 for FY2024, down 100.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $0.

KPT.TO free cash flowKPT.TO FCFKPT.TO FCF 2024KPT.TO free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · KP Tissue Inc. · KP Tissue Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026